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Human neural stem cells hold great promise for research and therapy in neural disease. We 
describe the generation of integration-free and expandable human neural progenitor cells 
(nPcs). We combined an episomal system to deliver reprogramming factors with a 
chemically defined culture medium to reprogram epithelial-like cells from human urine into 
nPcs (huinPcs). these transgene-free huinPcs can self-renew and can differentiate into 
multiple functional neuronal subtypes and glial cells in vitro. Although functional in vivo 
analysis is still needed, we report that the cells survive and differentiate upon transplant into 
newborn rat brain. 
Several neural disorders have no effective drug treatment at present, and stem cells offer hope for 
those suffering from these debilitating diseases. There has been intense interest in obtaining 
human neural stem cells (NSCs) that may be used to treat neural disorders or to study them in the 
laboratory. The isolation and use of NSCs from either fetal or adult human tissue remain 
challenging because of ethical concerns and immune rejection1,2. Induced pluripotent stem cell 
(iPSC) technology provides a promising solution to this problem because it may be used to 
generate patient-specific cells for autologous engraftment3–6. Indeed, iPSCs from patients with 
neural diseases have been established successfully, such as with Parkinson’s disease7,8, 
Huntington’s disease7 and Alzheimer’s disease9. Differentiation of such iPSCs along the neural 
lineage and modeling of disease in vitro could increase our mechanistic understanding of these 
diseases, enable drug screening and eventually provide functional cells for autologous 
transplantation. However, the differentiation of human iPSCs into NSCs is inefficient, time 
consuming and variable among different iPSC lines6. Moreover, pluripotent cells such as iPSCs 
pose the risk of teratomas when transplanted in vivo. To attempt to circumvent these problems, 
new approaches have been devised to convert one somatic cell type to another without full 
reprogramming to the pluripotent state. Notably, functional neurons, termed induced neurons, 
have been generated directly from fibroblasts by retroviral delivery of neural-specific transcription 
factors or microRNAs10–15. The direct conversion approach has also been successfully applied to 
reprogram mouse fibroblasts into hepatocyte-like cells16,17, cardiomyocytes17 and pancreatic β 
cells18, using virally delivered reprogramming factors. 
An attractive alternative to using induced neurons or iPSC-derived neurons is to generate 
self-renewable NPCs from a patient’s own somatic cells, and to do so avoiding viral integration of 
the genes encoding reprogramming factors. In this report, we describe the integration-free 
generation of hUiNPCs, human NPCs from epithelial-like cells in human urine. The cells could be 
expanded in vitro and differentiate into neuronal subtypes and astrocytes. 
 
RESULTS 
Generation of integration-free NPCs from human urine cells 
We have recently shown that human urine contains live cells that can be efficiently reprogrammed 
into iPSCs19. In an effort to further improve this approach to derive naive iPSCs, we adopted 
integration-free and feeder-free methods to reprogram human urine cells (HUCs). We purified 
viable HUCs from the urine (Fig. 1a) of a healthy 37-year-old male donor and transfected them 
with oriP/EBNA episomal vectors carrying a combination of reprogramming factors encoded by 
OCT4 (POU5F1), SOX2, SV40LT, KLF4 and microRNA cluster MIR302–367 through 
electroporation20,21 and cultured the transfected cells in defined basal medium containing FGF2 
(ref. 22) and a cocktail of small molecules (5i) known to promote reprogramming: CHIR99021, 
PD0325901, A83-01, thiazovivin and DMH1 (refs. 23–29). We observed that the transfected 
HUCs showed rapid morphological changes in these cultures. Notably, as early as day 12 
post-electroporation, we began to observe the formation of compact colonies (Fig. 1b). The 
average colony-forming efficiency was around 0.2% as determined from the initial number of 
HUCs used in each reprogramming experiment and was consistent for three different donors (n = 
3, Supplementary Fig. 1). This is in sharp contrast to HUCs electroporated with the same episomal 
vectors but cultured in TeSR22, in which iPSC colonies appeared at around 25 d after 
electroporation (Supplementary Fig. 2). We were intrigued by the appearance of these early 
colonies and characterized them further. 
We picked colonies from both TeSR and 5i cultures and cultured them further on Matrigel, in 
their original media. Surprisingly, the domed colonies that had emerged in the 5i medium assumed 
a rosette-like morphology typical of NPCs (Fig. 1c). In contrast, colonies grown in TeSR medium 
grew as typical human iPSC colonies (Supplementary Fig. 2). We hypothesized that cells 
undergoing reprogramming in the 5i medium might preferentially commit to the NPC fate at an 
early stage (around day 12) before the establishment of a full pluripotent state (around day 25). To 
test this hypothesis, we randomly picked 20 individual colonies from the reprogramming culture 
in 5i at day 14 or 15 and examined the expression of NSC and pluripotency markers without 
further re-plating or culturing. By quantitative real-time PCR (qRT-PCR) analysis, we observed 
robust expression of typical NSC genes such as SOX2 and NES (encoding nestin) in all 20 
colonies. We did not observe substantial activation of genes encoding pluripotency markers such 
as OCT4 and NANOG or other lineage markers such as T (brachyury) and SOX17 (Fig.  1d and 
Supplementary Fig. 2). We did detect low expression of SOX17 in HUCs and some picked 
colonies, which is consistent with the endodermal origin of HUCs (Supplementary Fig. 2). PAX6, 
another NSC gene, was activated at day 14, but more substantially so at day 15, which suggests a 
dynamic process of reprogramming toward a neural fate (Fig. 1d). 
We further immunostained the 5i colonies at day 15 for known embryonic stem cell (ESC) or 
NSC markers. The colonies were negative for pluripotency markers such as TRA-1-60, TRA-1-81 
and NANOG but stained positively for PAX6 and nestin (Fig. 1e–i). We also failed to detect 
substantial activation of OCT4 and NANOG at earlier stages of reprogramming (days 6–8) 
(Supplementary Fig. 2). It has been reported that mouse embryonic fibroblasts reprogrammed with 
standard pluripotency factors (Oct4, Sox2, Klf4 and c-Myc) can be switched to a neural identity 
by transferring the virally infected cells to neural medium containing fibroblast growth factors and 
epidermal growth factor30. However, we did not observe NPC-like colonies among the 
transfected HUCs grown in the identical neural medium reported earlier (data not shown). 
Furthermore, when we replaced HUCs with human dermal fibroblasts, we observed no NPC-like 
cells under the conditions that we used for HUC reprogramming with 5i (data not shown). Taken 
together, our results suggest that the compact, dome-shaped colonies that appeared early during 
reprogramming in 5i medium may have committed to an NPC fate rather than a pluripotent one. 
We observed the same outcome for HUCs donated by two additional individuals ages 10 and 25 at 
an average reprogramming efficiency of around 0.2% based on the starting number of HUCs 
(Supplementary Fig. 1). 
To characterize the proliferative potential of hUiNPCs, we dissociated the re-plated rosette 
colonies and seeded them as single cells on Matrigel (Fig. 1j). We observed that these cells grew 
well and exhibited typical NPC morphology. When cultured in suspension, the hUiNPCs grew as 
neural spheres, a typical property of NSCs31, and could be expanded over multiple passages with 
a high proliferation rate (Fig. 1k). The cells expressed high levels of the proliferation marker Ki67 
(Fig. 1l). hUiNPC spheres expanded for 11 passages also showed homogenous expression (>90% 
of cells) of the neural ectoderm transcription factors PAX6 (ref. 32) and SOX1 as well as the 
neural stem cell markers SOX2 and nestin (Fig. 1m–o and Supplementary Fig. 2). In contrast, we 
did not detect the expression of pluripotency markers such as OCT4 or markers for other germ 
layer lineages such as SOX17 and T (Fig. 1p,q and Supplementary Fig. 2). The expanded 
hUiNPCs at passage 6 no longer harbored the reprogramming factors encoded by OCT4, SOX2, 
KLF4, SV40LT or MIR302–367, nor did they carry the genes from the episomal vector backbone 
(Fig. 1r), yet they possessed normal karyotypes (Fig. 1s). We also performed whole-genome 
sequencing of select hUiNPCs and confirmed that they are of human origin (data not shown). 
hUiNPCs show distinct gene expression profiles 
We profiled the global gene expression patterns of hUiNPCs, the parental HUCs and the urine 
cell–derived iPSCs (Uri_iPSCs). The hUiNPCs clustered independently from the starting HUCs 
(UriC1 and UriC2) and the urine iPSCs (Uri_iPSC1, Uri_iPSC2) (Fig. 2a). Further 
paired-comparison analysis revealed distinct expression profiles between hUiNPCs and Uri_iPSCs 
derived from the same starting cells: neural genes were more highly expressed in hUiNPCs, and 
pluripotency genes were more highly expressed in Uri_iPSCs (Fig. 2b). By comparing the 
expression profiles between HUCs and hUiNPCs, we identified 720 genes related to neuronal 
function that were upregulated in hUiNPCs (Fig. 2c,d and Supplementary Table 1). In contrast, the 
HUC expression profiles were enriched for genes related to endothelial, angiogenic or epithelial 
functions (Fig. 2c,d and Supplementary Table 2), indicating that the HUCs might be of endothelial 
or epithelial origin. 
hUiNPCs differentiate into cell subtypes of neural lineage  
The promise of NPCs relies on their capacity to differentiate into functional subtypes of neural 
cells (Fig. 3). We observed that hUiNPCs (at passage 5) could efficiently give rise to β III tubulin 
(TUJ1)-positive neurons (at an average efficiency of 76.7% of total cells in three experiments) and 
glial fibrillary acid protein (GFAP)-positive astrocytes (at an average efficiency of 7.8% of total 
cells in three experiments) upon in vitro spontaneous differentiation (Fig. 3a,b,l). Moreover, this 
differentiation potential was well maintained throughout prolonged in vitro expansion (passage 8) 
(Fig. 3l). Unlike mouse NPCs, human NPCs do not give rise to oligodendrocytes during 
spontaneous in vitro differentiation33,34. However, in the presence (for 3 weeks) of factors 
(PDGF-AA, NT3, IGF1) known to promote oligodendrocyte differentiation, we observed O4- and 
PDGFR-α–positive oligodendrocyte-like cells (Fig. 3h,i). We observed, by staining with neuronal 
subtype–specific markers, that hUiNPCs could generate various subtypes of neurons including 
mature glutamatergic, GABAergic and dopaminergic neurons at 37.6%, 15.2% and 6.5%, 
respectively (Fig. 3e–g, respectively, and Fig. 3k). We also observed DCX-positive immature 
neurons in the differentiation culture (Fig. 3d). Finally, 85.4% of neurons derived from hUiNPC 
were positive for synapsin, indicating that most of the neurons were likely to be excitable (Fig. 
3j,k). 
hUiNPC-derived neurons are functional in vitro 
We used standard whole-cell patch-clamp recordings to examine the function of hUiNPC-derived 
neurons (Fig. 4). We observed rapidly inactivating inward currents and persistent outward currents 
in response to depolarizing voltage steps that could be blocked by tetrodotoxin and 
tetraethylammonium (Fig. 4b,c). We also observed that the neurons generated repetitive trains of 
action potentials (Fig. 4a). Notably, the hUiNPC-derived neurons exhibited strong postsynaptic 
currents spontaneously or in response to excitatory or inhibitory neurotransmitter stimulation (Fig. 
4d–f; 5 out of 5 neurons for each experiment). Together, these data demonstrate that hUiNPCs can 
give rise to mature, functional neurons invitro. 
Transplantation of hUiNPCs in vivo 
To examine the potential of hUiNPCs invivo, we transplanted these cells into the striatum of 
newborn rats (n = 12 rats) (Fig. 5a) and analyzed the brains of the animals 4 weeks after 
transplantation. We observed human nuclear antigen (hNA)-stained cells that had survived and 
migrated in the host brain (Fig. 5) and did not observe teratoma formation in any of the 
transplanted rats (Fig. 5a). Some hNA-positive cells apparently remained as NPCs, as they stained 
positively for the NSC marker nestin (Fig. 5b and Supplementary Fig. 3). We also observed 
hNA-positive cells that expressed the astrocyte marker GFAP and the neuronal marker TUJ1 (Fig. 
5b), which indicated that the engrafted hUiNPCs could give rise to both neurons and astrocytes in 
vivo. A full characterization of the stability, differentiation potential and function of these cells in 
vivo will require further study. 
DISCUSSION 
We describe here the notable finding that functional NPCs can be generated from somatic cells 
with the same factors known to be capable of reprogramming to pluripotency when cells are 
cultured in specially defined conditions. Recently, several reports have shown that mouse 
fibroblasts can be reprogrammed directly into neural stem cells using virally delivered 
reprogramming factors35–38. In contrast, our method uses episomal factors for rapid and efficient 
derivation of integration-free NPCs from cells in human urine. 
We showed that hUiNPCs arise at day 12–15, before the emergence of iPSCs at day 24–28 (Fig. 
1). Further, the colonies express NSC markers, but we did not detect the expression of 
pluripotency markers (Fig. 1d–i). However, on the basis of our current data, which were obtained 
from mixed populations of cells, we cannot rule out the possibility that some cells in the 
reprogramming culture pass through a fully pluripotent state. Single-cell analysis will help clarify 
this question39,40 and may also yield insight at the molecular level into how different cell fate 
decisions can be triggered in somatic cells by the same reprogramming factors. 
We have applied our approach successfully to generate hUiNPCs from three individuals at ages 10, 
25 and 37 years, with an average reprogramming efficiency around 0.2% (Supplementary Fig. 1). 
We envision that our protocols can be further applied to HUCs isolated from patients with neural 
disorders such as Parkinson’s disease, Alzheimer’s disease or other neurodegenerative diseases. 
These patient-specific hUiNPCs should be useful for modeling disease and for drug screening. 
hUiNPCs may in the future also prove useful for cell therapy, such as for patients with  
spinal cord injury. Our feeder- and serum-free culture system for generating these cells can enable 
this application. The overall efficiency of ~0.2% for the generation of hUiNPCs from HUCs is 
operationally adequate for current research, although future improvements to efficiency could be 
made, as has been accomplished for iPSC generation41. 
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Isolation and culture of HUCs. Three donors were recruited for urine samples with informed 
consent based on IRB approval (no. GIBH-IRB02-2009002) at Guangzhou Institutes of 
Biomedicine and Health (GIBH). The procedures and purposes for isolating urine cells and 
generating stem cells were explained to the donors in detail, and questions, if any, were answered 
in full. We then obtained a formal signed consent form and collected a total of ~500 ml of urine 
from each donor. The subsequent procedures for isolating human urine cells and generating stem 
cells were performed as approved. The method for isolating urine cells was modified from a 
previous established protocol19. Briefly, urine samples were collected at the mid-stream from 
three individuals and centrifuged to collect the exfoliated cells. The primary urine cells were then 
processed and cultured in urine cell medium consisting of a 1:1 mixture of DMEM/F12 culture 
medium supplemented with 10% of FBS (FBS, PAA), 0.1 mM non-essential amino acids (NEAA), 
1 mM GlutaMAX (Life Technologies), 0.1 mM β-mercaptoethanol and SingleQuot Kit CC-4127 
REGM (Lonza). 
hUiNPC generation. For reprogramming, an oriP/EBNA1-based pCEP4 episomal vector 
containing the OCT4, SOX2, KLF4 and SV40LT genes20 and a pCEP4 vector carrying the 
miR302–367 precursor21 were co-transfected into urine cells via nucleofection (Amaxa Basic 
Nucleofector Kit for primary mammalian epithelial cells with the T-013 program, Lonza). 
Transfected urine cells were directly plated to Matrigel-coated six-well plates (1–3 × 105 cells per 
well) in urine cell culture medium. On day 2 post-transfection, the media were changed into 
reprogramming media mTeSR or 5i (mTeSR supplemented with 5i 0.5 μM A83-01, 1 μM 
PD0325901, 3 μM CHIR99021, 0.5 μM thiazovivin and 0.2 μM DMH1). Medium was changed 
every 2 d during the reprogramming. Fifteen days after transfection, colonies were picked up in 5i 
and transferred onto a new Matrigel plate. For further passaging, the cells were dissociated to 
small clusters or single cells for suspension in flasks containing neural growth medium as neural 
spheres (1:1 of DMEM/F12 supplemented with 1% N2 (Invitrogen) and Neurobasal medium 
supplemented with 2% B27 (Invitrogen) supplemented with 20 ng/ml bFGF and 20 ng/ml EGF). 
Neural differentiation in vitro. hUiNPCs were cultured in neural medium N2B27 containing 
EGF and bFGF. For pan-neuronal differentiation, hUiNPC spheres were plated on Matrigel-coated 
coverslips and cultured in neural N2B27 medium with the withdrawal of EGF and bFGF and the 
addition of neurotrophic factors, BDNF, GDNF, CNTF, IGF1 (all at 10 ng/ml, Peprotech) and 
1 μM cAMP to improve neuronal survival. hUiNPCs differentiated for 2 weeks were then 
examined for the expression of neuronal markers and an astrocyte marker. To derive 
oligodendrocytes, hUiNPCs were plated on poly-l-ornithine/laminin substrate and cultured in 
DMEM/F12 supplemented with 1% N1 (Sigma), biotin (100 ng/ml), PDGF-AA (20 ng/ml, 
Peprotech), NT3 (20ng/ml, Peprotech), 1 μM cAMP and bFGF (10 ng/ml) for 1 week. Afterward, 
bFGF was replaced by IGF1 (10 ng/ml) for another 3 weeks. All media were replenished every 2 
d. 
Quantitative real-time PCR. Total RNAs were extracted with Trizol (Invitrogen). qRT-PCR was 
performed using a Thermal Cycler Dice Real Time System and SYBR Premix EX Taq  
(Takara). β-actin was used for qRT-PCR normalization, and all data were measured in triplicate. 
Primer sequences are listed in Supplementary Table 3. 
Analysis of gene integration by PCR. Genomic DNAs were extracted using the Wizard Genomic 
DNA Purification Kit (Promega) for PCR analysis using primers (Supplementary Table 3) that 
specifically amplify the exogenous transgenes as described20. 
Immunocytochemistry. Cells were fixed in 4% paraformaldehyde dissolved in 0.1 M phosphate 
buffer (PB) for 20 min. After several washes with 0.01 M phosphate-buffered saline (PBS), the 
cultures were incubated with the primary antibodies in PBS plus 1% BSA, 10% normal goat 
serum and 0.3% Triton X-100 overnight at 4 °C. The primary antibodies are listed in 
Supplementary Table 4. Primary antibodies were visualized with species-specific secondary 
antibody conjugated to the fluorescent labels Alexa 568 or 488 (1:400; Invitrogen). Cells were 
mounted in anti-fade medium containing 4′,6-diamidino-2-phenylindole (Sigma) to counterstain 
nuclei. At least 500 DAPI-positive cells from five randomly selected fields were counted to 
calculate the fraction of each lineage. Results are mean ± s.e.m. of data from three experiments 
unless stated otherwise in legends. Cells were imaged on a Zeiss Axio Imager A1 microscope or a 
Leica TCS SP2 Spectral confocal microscope. 
Electrophysiological analysis. Whole-cell patch-clamp recording techniques were used to study 
the physiological properties of hUiNPC-derived neurons in culture with borosilicate glass pipettes 
(resistance 5–10 MΩ) using an Axopatch 200B amplifier (Axon Instruments for Molecular 
Devices). Both the spontaneous postsynaptic current and current response to exogenous focal 
application of glutamate and GABA were recorded. Pressure ejection was used to puff 1 mM 
glutamate (10 p.s.i., 100 ms) and 1 mM GABA (10 p.s.i., 100 ms), and the holding voltages were 
−80 mV and 0 mV, respectively. The patch pipette internal solution contained (in mM): 136.5 
K-gluconate, 0.2 EGTA, 10 HEPES, 9 NaCl, 17.5 KCl, 4 Mg-ATP and 0.3 Na-GTP, adjusted with 
KOH to pH 7.2, 285 osmol/l. For the recording of voltage-gated currents and action potentials, we 
used the following composition of the intracellular solution (in mM): 140 potassium 
methanesulfonate, 10 HEPES, 5 NaCl, 1 CaCl2, 0.2 EGTA, 3 ATP-Na2, 0.4 GTP-Na2, pH 7.3 
(adjusted with KOH). The external solution contained (in mM): 120 NaCl, 1.2 KH2PO4, 1.9 KCl, 
26 NaHCO3, 2.2 CaCl2, 1.4 MgSO4, 10 d-glucose, 7.5 HEPES (pH with NaOH to 7.3). The bath 
solution was equilibrated with 95% O2 and 5% CO2 before use. Resting potentials were 
maintained at about −60 mV. Signals were sampled at 10 kHz using a Digidata1440A 
analog-to-digital converter and acquired and stored on a computer hard drive using pClamp10 
software. Data were analyzed using pClamp10 (Clampfit). 
Karyotype analysis. hUiNPCs were used for karyotype analysis as described42. Cells were 
grown in 10-cm plates, and demecolcine (Dahui Biotech) was added to a final concentration of 50 
μg/ml for 40 min. Cells were then trypsinized, pelleted by centrifugation at 200g for 5 min, 
resuspended in 8 ml of 0.075 M KCl and incubated for 20 min at 37 °C. Fixative solution 
composed of one part acetic acid and three parts methanol was added to a final  
volume of 10 ml, mixed gently and incubated for 10 min at 37 °C. After further centrifugation, the 
supernatant was removed, and ice-cold fixative solution composed of one part acetic acid and 
three parts methanol was added to a final volume of 10 ml. Cells were dropped on a cold slide and 
incubated at 75 °C for 3 h. Belts were treated with trypsin and colorant, and metaphase states were 
analyzed on an Olympus BX51 microscope. 
Whole-genome expression analysis. Total RNAs were extracted from HUCs, hUiNPCs and 
Uri_iPSCs and quantified by the NanoDrop ND-1000. RNA integrity was assessed by standard 
denaturing agarose gel electrophoresis. About 5 μg total RNA was used for the reverse 
transcription with Invitrogen’s Superscript Double-Stranded cDNA Synthesis Kit. Labeled cDNA 
was synthesized by in vitro transcription using NimbleGen one-color DNA labeling kit. Array 
hybridization was performed with the NimbleGen Hybridization System and followed by a wash 
with the NimbleGen wash buffer kit. Arrays were scanned with the Axon GenePix 4000B 
microarray scanner. Data were analyzed with NimbleScan software (v.2.5). 
In vivo transplantation and tissue processing. The protocol used for newborn rat was reviewed 
and approved by the animal care committee at GIBH. For hUiNPCs transplantation, 12 newborn 
Sprague Dawley rats were used in the study. hUiNPC neurospheres were gently dissociated into 
single cells with Accutase (Millipore) and resuspended in N2 medium supplemented with 10 
μg/ml BDNF, 10 μg/ml GDNF, 10 μg/ml CNTF and 10 μg/ml  
42. Esteban, M.A. et al. Generation of induced pluripotent stem cell lines from Tibetan miniature 
pig. J. Biol. Chem. 284, 17634–17640 (2009).  
IGF1 at a concentration of 1.0 × 105 cells/μl and placed on ice for the duration of the grafting 
session. One microliter of cell suspension was slowly injected into each of the striatum of 
cryoanesthetized newborn rats through a Hamilton syringe with the sharpened tip. At 2 and 4 
weeks following transplantation, rats were anesthetized and perfused intracardially with 0.01 M 
PBS, pH 7.4, followed by 100–200 ml of fixative solution containing 4% paraformaldehyde in 0.1 
M PBS, pH 7.4. The brains were harvested and post-fixed in fresh fixative solution overnight and 
subsequently placed in 30% sucrose, 0.1 M PBS at 4 °C for 2–3 d. The samples were then cut into 
25-μm cross-sections on a microtome. The serial sections were collected in 0.01 M PBS and kept 
at 4 °C for further study. 
Immunohistochemistry of brain sections. Donor cells were identified by an antibody to a 
human-specific nuclear antigen (hNA). Immunopositive cells were double labeled with antibodies 
to β III tubulin (TUJ1), GFAP and nestin (Supplementary Table 4). Species-specific 
fluorescence-conjugated secondary antibodies conjugated to Alexa 488 (1:400; Molecular Probes) 
were applied for 2 h at 20 °C. Sections were then counterstained with 
4′,6-diamidino-2-phenylindole to stain nuclei and coverslipped with anti-fade mounting medium 
(FluorSave; Calbiochem). A Zeiss 710 NLO spectral confocal microscope was used for all 
immunofluorescence studies. 
 
 Figure 1 | Generation and expansion of integration-free NPCs from human urine cells. (a–d) Generation of NPCs 
from human urine cells. Epithelial-like cells isolated from human urine (a) were transfected with episomal vectors 
encoding reprogramming factors and miR302–367 and cultured in defined medium (5i) on Matrigel. Colonies 
arising at day 12 (b) were picked and re-plated onto Matrigel (c) or directly analyzed for marker expression by 
qRT-PCR (d). The plot shows relative expression levels of the indicated genes in colonies picked at days 14 and 
15 compared to levels in HUCs and iPSCs (abbreviated as UC and iPS, respectively). Note that levels of NANOG 
in iPSCs are invisible on the plot at this scale. The value of NANOG in iPSCs was 0.0061, compared with 
0.0000036 in HUCs and 0.00165 in colonies at day 14 and 0.000899 in colonies at day 15. (e–i) Micrographs show 
immunostains of colonies for the indicated markers (day 15). Lower panel of g shows a positive control for the 
antibody to NANOG. (j–q) Expansion of hUiNPCs. Representative morphology of hUiNPCs cultured on Matrigel 
(j) or in suspension as neural spheres (k) is shown. (k) Left, growth curve of hUiNPCs cultured as neural spheres. 
Right, neural spheres before and after passage (P). (l) hUiNPCs stained for Ki67 and nestin (P6). (m–p) 
Immunostains of expanded hUiNPCs (P5) for the indicated markers. (q) qRT-PCR analysis of markers expressed 
by expanded hUiNPCs (P5). (r) PCR detection of integrated transgenes in expanded hUiNPCs (iNPC, P6). Primers 
were designed to detect exogenous reprogramming factors. Untransfected urine cells served as the negative control. 
HUCs transiently transfected with reprogramming factors served as the positive control. (s) Karyotype of 







 Figure 2 | Global gene expression analysis of hUiNPCs. (a) Pearson correlation analyses of global gene expression 
in HUCs (UriC1 and UriC2) and in neural progenitor cells (UiNPC1 and UiNPC2) and iPSCs (Uri_iPSC1 and 
Uri_iPSC2) derived from them. (b) Comparison of global gene expression profiles of a Uri_iPSC and UiNPC line 
derived from the same starting cell sample. R, Pearson correlation coefficient. Selected neural-specific (purple) and 
embryonic stem cell (ESC)-specific (red) genes are highlighted. (c) Differential expression profile between 
parental HUCs (above) and hUiNPCs (below). Yellow dashed lines correspond to a twofold change. The 
differentially expressed genes (red) are those with an adjusted P value 0.05 and fold change 3. Known 
NPC-specific (green) and ESC-specific (purple) genes are depicted. (d) Functional annotations of genes 
differentially expressed between HUCs (top) and hUiNPCs (bottom). Gene ontology (GO) statistics for these 
genes were computed using the hypergeometric test, and enriched GO terms (biological processes) for each cell 
type are plotted with −log
10 






 Figure 3 | Differentiation of hUiNPCs in vitro. (a) Bright-field image of spontaneously differentiated cells from 
hUiNPCs. (b–j) Immunostains of spontaneously differentiated hUiNPCs with antibodies against the indicated 
markers: GFAP, astrocyte marker; TUJ1, pan-neuronal marker; NeuN and MAP2, mature neuronal markers; DCX, 
immature neuronal marker; glutamate (Glu), GABA and TH, subtype-specific neuronal markers; O4, 
oligodendrocyte marker; PDGFR-α, oligodendrocyte progenitor marker; SYN (and arrow in j), synapsin I. (k) 
Percentage of each neuronal subtype (left) and of neurons with synapsin staining (right) out of total neurons. Total 
neurons were determined by staining with pan-neuronal marker MAP2 or TUJ1. At least 500 DAPI-positive cells 
from five randomly selected fields were counted to calculate the fraction of each lineage (Online Methods). (l) 
Percentage of neurons (TUJ1-positive cells) and astrocytes (GFAP-positive cells) in spontaneously differentiated 
hUiNPCs at different passages (P). Total cells were determined by DAPI stain. Scale bars: 50 μm (a–g), 20 μm 












 Figure 4 | hUiNPC-derived neurons are functional in  vitro. (a) Current-clamp recording showing a representative 
train of action potentials in a neuron differentiated from hUiNPCs. Intracellular injected currents were step 
currents of −20, 30, 50, 60, 70, 80, 90 and 100 pA. Right, current trace at 90-pA injected current. (b,c) 
Representative recordings of voltage-gated ion channels from a neuron differentiated from hUiNPCs. An inward 
current was observed and could be blocked by tetrodotoxin (TTX) (b), and an outward current could be blocked by 
tetraethylammonium (TEA) (c). (d–f) Analysis of postsynaptic currents in hUiNPC-derived neurons. Shown are 
representative traces of spontaneous postsynaptic currents (PSCs) (d), of excitatory postsynaptic currents in cells 
clamped at −80 mV in response to l-glutamate puffs (e), and of inhibitory postsynaptic currents in cells clamped at 




 Figure 5 | In  vivo transplant of hUiNPCs. (a) Schematic shows the transplant location (striatum) of hUiNPCs into 
the brain of newborn rats. Micrographs show immunostains for human nuclear-specific antigen (hNA) and DAPI 
stain on a brain section at the transplant site. (b) Immunostains for the indicated markers of brain sections at the 
transplant site 4 weeks after cells were transplanted. Scale bars: 50 μm (a), 20 μm (b, left), 10 μm (b, right).  
 
